Among women with GDM (n = 123), the use of insulin therapy was higher in women with obesity (59.5% vs. 41.5%), but the total insulin doses were similar between the two groups (20.95 ± 17.06 vs. 19.92 ± 14.21 UI). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.